These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24833182)

  • 1. Resolution of persistent pigment epithelial detachment secondary to polypoidal choroidal vasculopathy in response to Aflibercept.
    Cheung CM; Mohla A; Wong TY
    Eye (Lond); 2014 Sep; 28(9):1148-9. PubMed ID: 24833182
    [No Abstract]   [Full Text] [Related]  

  • 2. Aflibercept for the treatment of refractory polypoidal choroidal vasculopathy.
    Yonekawa Y
    Can J Ophthalmol; 2013 Jun; 48(3):e59-60. PubMed ID: 23769799
    [No Abstract]   [Full Text] [Related]  

  • 3. One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy.
    Yamamoto A; Okada AA; Kano M; Koizumi H; Saito M; Maruko I; Sekiryu T; Iida T
    Ophthalmology; 2015 Sep; 122(9):1866-72. PubMed ID: 26088619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Hara C; Sawa M; Sayanagi K; Nishida K
    Retina; 2016 Jan; 36(1):37-45. PubMed ID: 26383709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy.
    Hosokawa M; Shiraga F; Yamashita A; Shiragami C; Ono A; Shirakata Y; Kimura S; Shiode Y; Kawata T; Hosogi M; Fujiwara A; Morizane Y
    Br J Ophthalmol; 2015 Aug; 99(8):1087-91. PubMed ID: 25712826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal pigment epithelial atrophy after anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.
    Cho HJ; Kim K; Lim SH; Kang DH; Kim JW
    Br J Ophthalmol; 2020 Oct; 104(10):1443-1447. PubMed ID: 31896542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term efficacy of intravitreal aflibercept for patients with treatment-naïve polypoidal choroidal vasculopathy.
    Ijiri S; Sugiyama K
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):351-7. PubMed ID: 25023147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Komuku Y; Iwahashi C; Gomi F
    Jpn J Ophthalmol; 2020 May; 64(3):265-270. PubMed ID: 32206935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics of Polypoidal Choroidal Vasculopathy and Anti-Vascular Endothelial Growth Factor Treatment Response in Caucasians.
    Kokame GT; Liu K; Kokame KA; Kaneko KN; Omizo JN
    Ophthalmologica; 2020; 243(3):178-186. PubMed ID: 31707394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection.
    Saito M; Kano M; Itagaki K; Ise S; Imaizumi K; Sekiryu T
    Jpn J Ophthalmol; 2016 Jan; 60(1):35-41. PubMed ID: 26350229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EFFICACY OF INTRAVITREAL INJECTION OF CONBERCEPT IN POLYPOIDAL CHOROIDAL VASCULOPATHY: Subgroup Analysis of the Aurora Study.
    Qu J; Cheng Y; Li X; Yu L; Ke X;
    Retina; 2016 May; 36(5):926-37. PubMed ID: 26595362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal Aflibercept and Ranibizumab Injections for Polypoidal Choroidal Vasculopathy.
    Cho HJ; Kim KM; Kim HS; Han JI; Kim CG; Lee TG; Kim JW
    Am J Ophthalmol; 2016 May; 165():1-6. PubMed ID: 26921806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic polypoidal choroidal vasculopathy in Caucasians: The POLYON real-life study in 50 naive patients.
    El Chehab H; Kodjikian L; Lagenaite-Desmaizère C; Agard E; De Bats F; Mathis T; Dot C
    Eur J Ophthalmol; 2020 Sep; 30(5):948-955. PubMed ID: 31505993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY: As Needed Versus Fixed Interval Dosing.
    Inoue M; Yamane S; Taoka R; Arakawa A; Kadonosono K
    Retina; 2016 Aug; 36(8):1527-34. PubMed ID: 26710307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
    Kim JH; Chang YS; Lee DW; Kim CG; Kim JW
    Jpn J Ophthalmol; 2018 Jan; 62(1):54-62. PubMed ID: 29188462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypoidal Choroidal Vasculopathy Occurring in the Context of Large Colloid Drusen.
    Mathis T; Kodjikian L; Mauget-Faÿsse M; Feldman A
    Ophthalmic Surg Lasers Imaging Retina; 2016 Dec; 47(12):1154-1156. PubMed ID: 27977841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
    Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANGIOGRAPHIC FINDINGS OF RANIBIZUMAB-RESISTANT POLYPOIDAL CHOROIDAL VASCULOPATHY AFTER SWITCHING TO A TREAT-AND-EXTEND REGIMEN WITH INTRAVITREAL AFLIBERCEPT.
    Azuma K; Obata R; Nomura Y; Tan X; Takahashi H; Yanagi Y
    Retina; 2016 Nov; 36(11):2158-2165. PubMed ID: 27258669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF POLYPOIDAL CHOROIDAL VASCULOPATHY AND POLYPOIDAL CHOROIDAL NEOVASCULARIZATION.
    Inoue M; Balaratnasingam C; Freund KB
    Retina; 2015 Nov; 35(11):2265-74. PubMed ID: 26405770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.